Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial

Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial

Epistaxis is a common debilitating manifestation in hereditary hemorrhagic telangiectasia (HHT), due to mucocutaneous telangiectases. The epistaxis can be difficult to control despite available treatments. Dysregulated angiogenesis has been shown to be associated with telangiectases formation. Topic...

Full description

Bibliographic Details
Main Authors: Meir Mei-Zahav, Yulia Gendler, Elchanan Bruckheimer, Dario Prais, Einat Birk, Muhamad Watad, Neta Goldschmidt, Ethan Soudry
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
hereditary hemorrhagic telangiectasia
epistaxis
propranolol gel
epistaxis severity score
nasal endoscopy
antiangiogenic properties
Online Access:https://www.mdpi.com/2077-0383/9/10/3130

Internet

https://www.mdpi.com/2077-0383/9/10/3130

Similar Items